Suchergebnisse - "drug development"

PubPharm (9.303)

11

Physiologically Based Pharmacokinetic Modeling for Maribavir to Inform Dosing in Drug-Drug Interaction Scenarios with CYP3A4 Inducers and Inhibitors

enthalten in: Journal of clinical pharmacology | 2024

von Chen, G. | Sun, K. | Michon, I. | +5

12

Transcriptomic and western blot characterisation of the human CLEFF4 clone, a new rapid cell line replacement for the Caco2 model

enthalten in: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V | 2024

von Crowe, A.

13

From taboo to treatment : The emergence of psychedelics in the management of pain and opioid use disorder

enthalten in: British journal of clinical pharmacology | 2024

von Weleff, J. | Nunes, J. | Costa, G. | +3

14

Patient-Centric Approaches : Revolutionizing Rare Disease Drug Research

enthalten in: Infectious disorders drug targets | 2024

von Verma, A. | Awasthi, A.

15

Unveiling the Molecular Mechanism of Diosmetin and its Impact on Multifaceted Cellular Signaling Pathways

enthalten in: Protein and peptide letters | 2024

von Varshney, K. | Gupta, J. | Srivastava, R.

16

Enhanced efficacy of β-carotene loaded solid lipid nanoparticles optimized and developed via central composite design on breast cancer cell lines

enthalten in: Heliyon | 2024

von Dutta, R. | Elhassan, G. | Devi, T. | +7

17

Crystal Structure of Bimekizumab Fab Fragment in Complex with IL-17F Provides Molecular Basis for Dual IL-17A and IL-17F Inhibition

enthalten in: The Journal of investigative dermatology | 2024

von Adams, R. | Bunick, C. | Lawson, A. | +2

18

How to develop new systemic treatments in ultra-rare cancers with high unmet needs? The case of alveolar soft-part sarcoma

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Stacchiotti, S. | Bouche, G. | Herold, R. | +5

19

Bortezomib-induced peripheral neuropathy : Clinical features, molecular basis, and therapeutic approach

enthalten in: Critical reviews in oncology/hematology | 2024

von Yang, Y. | Zhao, B. | Lan, H. | +2

20

Assessing Environmental Risks during the Drug Development Process for Parasitic Vector-Borne Diseases : A Critical Reflection

enthalten in: ACS infectious diseases | 2024

von Ilbeigi, K. | Barata, C. | Barbosa, J. | +7